“Novo Nordisk launched the pill version of its popular GLP-1 weight loss
drug Wegovy in the US on Monday, marking a new era in obesity treatment.
The debut of the medication, the first of its kind, is set to accelerate a
price war, given that it is priced significantly lower than the jab-based
versions. The […]
The post Novo Nordisk Launches Weight Loss Pill in Us appeared first on
Human Progress.
https://humanprogress.org/novo-nordisk-launches-weight-loss-pill-in-us/View article
View summary
#^Novo Nordisk Launches Weight Loss Pill in Us“Novo Nordisk launched the pill version of its popular GLP-1 weight loss drug Wegovy in the US on Monday, marking a new era in obesity treatment.
The debut of the medication, the first of its kind, is set to accelerate a price war, given that it is priced significantly lower than the jab-based versions. The Danish pharmaceutical giant, which also makes Ozempic, had a rough 2025 as it lost ground to American rival Eli Lilly, but it is banking on the weight loss pill to regain its advantage.”
From
Semafor.
The post
Novo Nordisk Launches Weight Loss Pill in Us appeared first on
Human Progress.
